Inhibition of the lateral habenular CaMKⅡ abolishes naloxone-precipitated conditioned place aversion in morphine-dependent mice

Neurosci Lett. 2017 Jul 13:653:64-70. doi: 10.1016/j.neulet.2017.05.027. Epub 2017 May 17.

Abstract

Addictive substances mediate positive and negative states promoting compulsive drug use. However, substrates for aversive effects of drugs are not fully understood. We found that inactivation of the lateral habenula (LHb) by microinjection of tetrodotoxin (TTX) abolished naloxone-precipitated conditioned place aversion (CPA) in morphine-dependent mice. We also found that lateral habenular administration of KN-62, a specific inhibitor for calcium/calmodulin dependent protein kinase II (CaMKII), abolished naloxone-precipitated CPA in morphine-dependent mice. Furthermore, we found chronic morphine treatment induced overexpression of CaMKII in the LHb. In conclusion, our results suggest that the increased expression of CaMKII in the LHb is instrumental for morphine-driven aversive behaviors.

Keywords: Calcium/calmodulin dependent protein kinase II (CaMKII); Conditioned place aversion (CPA); Lateral habenula (LHb); Morphine.

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / administration & dosage
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives
  • Animals
  • Avoidance Learning / drug effects
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / antagonists & inhibitors
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism*
  • Conditioning, Classical / drug effects
  • Habenula / drug effects*
  • Habenula / metabolism
  • Habenula / physiology*
  • Male
  • Mice, Inbred C57BL
  • Morphine / administration & dosage*
  • Naloxone / administration & dosage*
  • Narcotic Antagonists / administration & dosage*
  • Narcotics / administration & dosage
  • Neurons / drug effects
  • Neurons / physiology
  • Substance Withdrawal Syndrome* / metabolism

Substances

  • Narcotic Antagonists
  • Narcotics
  • Naloxone
  • KN 62
  • Morphine
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2